Economides Vassiliki — SEC insider filings
SEC reporting owner CIK 1769674. 11 insider filings on record with FilingPulse; latest filed 2026-10-30.
Transaction summary — filings shown
Covers all 11 filings on record, filed 2021-01-11 to 2026-10-30. Counts and totals are arithmetic on values as filed — descriptive data, not a recommendation.
- Open-market purchases (code P, non-derivative): 2 legs across 2 filings — 12,750 shares, $30,471 total (shares × price as filed).
- Open-market sales (code S, non-derivative): 2 legs across 2 filings — 25,749 shares, $10,468 total (shares × price as filed).
- Other reported legs (grants, option exercises, tax withholding, gifts, derivative-security transactions, …): 13.
- Largest priced transaction: purchase of 12,000 shares @ $1.90 ($22,829) in Gritstone bio, Inc., filed 2023-05-24.
By issuer — same filings
Open-market purchase/sale legs on non-derivative securities, grouped by issuer. Role is as filed on the newest filing for that issuer. Dollar totals cover priced legs only (shares × price as filed). Ordered by priced transaction value, largest first.
| Issuer | Role (as filed) | Filings | Purchases (P) | Sales (S) | Other legs |
|---|---|---|---|---|---|
| Gritstone bio, Inc. (GRTS) | EVP, CHIEF FINANCIAL OFFICER | 8 | 1 leg · 12,000 sh · $22,829 | 2 legs · 25,749 sh · $10,468 | 12 |
| Kezar Life Sciences, Inc. (KZR) | SVP, Strategy & External Aff. | 2 | 1 leg · 750 sh · $7,642 | — | 1 |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | Chief Financial Officer | 1 | — | — | — |
Insider filings — Economides Vassiliki
| Filed | Form | Issuer | Reported transactions | Source |
|---|---|---|---|---|
| 2026-10-30 | 3 | ADIAL PHARMACEUTICALS, INC. (ADIL) | Holdings only — no transactions reported | EDGAR |
| 2025-04-08 | 4 | Gritstone bio, Inc. (GRTS) | Other (J): 250,437 @ $0 · Other (J): 215,000 (derivative) @ $0 · Other (J): 215,000 (derivative) @ $0 · Other (J): 138,000 (derivative) @ $0 | EDGAR |
| 2024-12-20 | 4 | Gritstone bio, Inc. (GRTS) | Sale (S): 12,000 @ $0.01 | EDGAR |
| 2024-05-17 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 27,128 @ $0 · Sale (S): 13,749 @ $0.75 · Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2024-02-05 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 35,000 @ $0 · Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2023-05-24 | 4 | Gritstone bio, Inc. (GRTS) | Purchase (P): 12,000 @ $1.90 | EDGAR |
| 2023-02-06 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 179,058 @ $0 | EDGAR |
| 2022-04-20 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 23,000 @ $0 · Grant/award (A): 138,000 (derivative) @ $0 | EDGAR |
| 2021-06-25 | 4 | Gritstone bio, Inc. (GRTS) | Grant/award (A): 215,000 (derivative) @ $0 | EDGAR |
| 2021-03-29 | 4 | Kezar Life Sciences, Inc. (KZR) | Purchase (P): 750 @ $10.19 | EDGAR |
| 2021-01-11 | 4 | Kezar Life Sciences, Inc. (KZR) | Grant/award (A): 110,000 (derivative) @ $0 | EDGAR |
FilingPulse's Form 4 archive currently extends back to 2021-01-06 and is expanding backward through EDGAR history; Forms 3 and 5 are covered live-forward since 2026-09-23 (no 3/5 history). Earlier filings by this insider may not be indexed yet. Names and roles are shown as filed.
GET https://api.filingpulse.io/v1/insider-trades?owner_cik=1769674 returns every filing on this page — normalized, with footnotes and derivative legs — and webhooks push new filings to you in seconds. Get a free API key → · API docs